Solid Biosciences Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $59.9M | $80.2M | $74.0M | $155.4M | $119.1M | $154.7M | $76.0M | $86.4M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $205.5M | $157.3M | $129.7M | $219.6M | $222.6M | $158.9M | $86.3M | $128.6M |
| Property, Plant & Equipment | $4.2M | $4.7M | $6.6M | $9.7M | $6.5M | $8.2M | $11.6M | $10.4M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $232.5M | $188.7M | $164.9M | $260.3M | $232.4M | $171.2M | $103.5M | $139.6M |
| Liabilities | ||||||||
| Accounts Payable | $3.2M | $4.2M | $2.0M | $3.2M | $4.5M | $3.3M | $7.1M | $3.7M |
| Total Current Liabilities | $33.5M | $30.3M | $14.5M | $22.5M | $23.6M | $24.5M | $18.3M | $12.5M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $52.5M | $51.4M | $38.5M | $48.6M | $24.2M | $39.1M | $23.4M | $14.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-957.8M | $-783.5M | $-658.8M | $-562.7M | $-476.8M | $-404.6M | $-316.3M | $-199.1M |
| Total Stockholders' Equity | $180.0M | $137.2M | $126.5M | $211.7M | $208.2M | $132.1M | $80.0M | $125.2M |